0 projects

H20-HEALTH-Health, demographic change and wellbeing

Personalised maxillofacial bone regeneration

Several tens of millions of European citizens are partially edentulous and have insufficient bone for placement of dental implants. Following FP7 REBORNE project on bone regeneration, the MAXIBONE consortium coordinated by INSERM wishes to perform a randomized controlled clinical trial on alveola...

Awarded: NOK 9.1 mill.

Project Period: 2018-2021

Location: Vestland og 2 andre

H20-HEALTH-Health, demographic change and wellbeing

Empathic, Expressive, Advanced Virtual Coach to Improve Independent Healthy-Life-Years of the Elderly

The EMPATHIC Research & Innovation project will research, innovate, explore and validate new paradigms and platforms, laying the foundation for future generations of Personalised Virtual Coaches to assist elderly people living independently at and around their home. Innovative multimodal face an...

Awarded: NOK 4.1 mill.

Project Period: 2017-2021

Location: Oslo

H20-MSCA-Marie Sklodowska-Curie actions

Personalised In-Silico Cardiology

Improving healthcare systems mandates a shift towards personalised and preventive management of disease. Specifically, the management of cardiovascular diseases has a huge impact on European society in terms of mortality, morbidity and healthcare costs, being responsible for 1.9 million deaths in...

Awarded: NOK 8.0 mill.

Project Period: 2017-2022

Location: Oslo og 2 andre

H20-MSCA-Marie Sklodowska-Curie actions

International impact of TALK©: a simple and practical approach to multi-professional structured feedback and debriefing, to be used after unplanned learning events in clinical environments.

TALK© is a communication tool which aims to guide multi-professional clinical teams learning and improving quality of patient care and patient safety together. It is a simple and practical approach to multi-professional structured feedback and debriefing, to be used after unplanned learning even...

Awarded: NOK 0.50 mill.

Project Period: 2017-2022

Location: Rogaland

H20-MSCA-Marie Sklodowska-Curie actions

Supporting Pioneer doctoral Researchers through 3i Knowledge partnerships

The SPaRK Programme is driven by the need to develop future leaders whose skills combine disciplinary excellence with a capacity for interdisciplinary and intersectoral working that creates genuinely disruptive thinkers. SPaRK recognises that genuinely game-changing intersectoral, international a...

Awarded: Hidden

Project Period: 2017-2022

Location: Oslo

H20-MSCA-Marie Sklodowska-Curie actions

FrontierResearchCompentences@CNAP

Chronic pain is a key societal challenge affecting one out of five adults and is in general poorly treated. This programme, FrontierResearchCompentences@CNAP (FRESCO@CNAP), aims to install 8 early stage researchers (ESRs) in a Centre-of-Excellence (CNAP) conducting frontline research on novel too...

Awarded: Hidden

Project Period: 2017-2022

Location: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Multiple manifestations of genetic and non-genetic factors in Multiple Sclerosis disentangled with a multi-omics approach to accelerate personalised medicine

The complex interactions between genetic and non-genetic factors produce heterogeneities in patients as reflected in the diversity of pathophysiology, clinical manifestations, response to therapies, disease development and progression. Yet, the full potential of personalized medicine entails biom...

Awarded: NOK 5.1 mill.

Project Period: 2017-2021

Location: Oslo

H20-INFRA-Research infrastructures

Paediatric Clinical Research Infrastructure Network

Children’s health is a major societal challenge for Europe and the world, requiring development of paediatric medicines and treatments strategies based on evidence derived from clinical trials demonstrating efficacy and safety in infants and children, rather than on uncritical extrapolation from ...

Awarded: NOK 0.45 mill.

Project Period: 2017-2021

Location: Vestland og 2 andre

H20-MSCA-Marie Sklodowska-Curie actions

Training, Research and Raising of Public Awareness in Cell Biology and Pathology of Neuroglia

The research in which the young scientists of the EU-GliaPhD consortium will be trained is centred on the role of neuron-glia interactions in brain function and pathology. Prompted by exciting discoveries of recent years, many academic research groups are currently focussing their research on the...

Awarded: NOK 2.7 mill.

Project Period: 2016-2021

Location: Oslo

H20-MSCA-Marie Sklodowska-Curie actions

High Performance Soft-tissue Navigation

Primary liver cancer, which consists predominantly of hepatocellular carcinoma (HCC), is the fifth most common cancer worldwide and the third most common cause of cancer mortality. A successful surgical resection of HCC requires complete removal of the tumour while sparing as much healthy tissue ...

Awarded: NOK 15.0 mill.

Project Period: 2016-2021

Location: Trøndelag - Trööndelage og 2 andre

H20-FET-Future and Emerging Technologies

A paradigm shift in cancer therapy – using mitochondria-powered chemiluminescence to non-invasively treat inaccessible tumours

Brain cancers such as glioblastoma multiforme (GBM) are practically incurable due to their location, invasiveness and highly aggressive nature. The use of light-based treatments of GBM by activating tumor-localized photosensitizers, such as in photodynamic therapy (PDT) has been clinically evalua...

Awarded: NOK 14.5 mill.

Project Period: 2016-2022

Location: Oslo

H20-SECURITY-Secure societies - Protecting freedom and security of Europe and its citizens

EnhANcing emergencY management and response to extreme WeatHER and climate Events

The ultimate purpose of ANYWHERE is to empower exposed responder institutions and citizens to enhance their anticipation and pro-active capacity of response to face extreme and high-impact weather and climate events. This will be achieved through the operational implementation of cutting-edge inn...

Awarded: NOK 5.6 mill.

Project Period: 2016-2019

Location: Trøndelag - Trööndelage og 2 andre

H20-HEALTH-Health, demographic change and wellbeing

Children’s Liver Tumour European Research Network

Liver cancer in the paediatric population is rare with an incidence approximately 1-1.5 per million population. The commonest tumour seen in the childhood population is hepatoblastoma (HB), usually seen in young children and infants. Much rarer (about 10% of paediatric liver cancers) is hepatocel...

Awarded: NOK 0.96 mill.

Project Period: 2016-2021

Location: Oslo

H20-MSCA-Marie Sklodowska-Curie actions

Wireless In-Body Environment

WiBEC (Wireless In-Body Environment Communications) is an Innovative Training Network for 16 young researchers, who will be recruited and trained in coordinated manner by Academia, Industry, and Medical Centres. This training will address the Social, Health, and Technology challenges of the H2020...

Awarded: NOK 12.2 mill.

Project Period: 2016-2019

Location: Trøndelag - Trööndelage og 2 andre

H20-MSCA-Marie Sklodowska-Curie actions

Image-Guided Surgery (IGS) and Personalised Postoperative Immunotherapy To Improving Cancer Outcome

The basic concept of our proposal is to develop nanoparticle-based encapsulated libraries of different immunotherapeutic biomolecules for treatment after surgery as part of a novel cancer management strategy. The current state-of-art for the management of cancer starts with surgery, after identif...

Awarded: NOK 5.1 mill.

Project Period: 2016-2019

Location: Vestland

H20-TWINING-Twinning of research institutions

Strategies towards Excellence in Immuno-Oncology

In 2013, the Science magazine announced Immunotherapy of cancer as the ‘Breakthrough of the Year’. The results of ongoing clinical studies with new cancer immunotherapeutics strongly support this enthusiasm. Following the lead of the top research groups, the Coordinator of the present proposal, M...

Awarded: NOK 1.5 mill.

Project Period: 2016-2018

Location: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Effect of ALlopurinol in addition to hypothermia for hypoxic-ischemic Brain Injury on Neurocognitive Outcome

Neonatal hypoxic-ischemic encephalopathy (HIE) is a major cause of death or long-term disability in infants born at term in the western world, affecting about 1-4 per 1.000 life births and consequently about 5-20.000 infants per year in Europe. Hypothermic treatment became the only established th...

Awarded: NOK 1.9 mill.

Project Period: 2016-2025

Location: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Clinical development of a dendritic-cell vaccine therapy for acute myeloid leukaemia

Eradicating minimal residual disease (MRD) in patients with acute myeloid leukaemia (AML) is an area of high unmet medical need. AML is a deadly rare disease that affects both children and adults. Approximately 45% of younger AML patients who are treated will be cured, and in older patients (>60 ...

Awarded: NOK 2.4 mill.

Project Period: 2016-2020

Location: Vestland

H20-HEALTH-Health, demographic change and wellbeing

Imaging the Force of Cancer

Cancer is the second leading cause of mortality in EU member states with ~90% of all cancer deaths caused by metastatic spread. Despite its significance, measuring metastatic potential as well as potential indicators of therapy efficacy remain unmet clinical challenges. Recently, it has been demo...

Awarded: NOK 6.5 mill.

Project Period: 2016-2021

Location: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Translational approaches to disease modifying therapy of type 1 diabetes: an innovative approach towards understanding and arresting type 1 diabetes – Sofia ref.: 115797

Preclinical type 1 diabetes (T1D) research has made important advances in recent years, but less progress has been made in translating findings from in vitro and animal models into effective clinical interventions. INNODIA aims to achieve a breakthrough in the way in which we study T1D to enable ...

Awarded: NOK 3.5 mill.

Project Period: 2015-2022

Location: Oslo

H20-CROSST-Cross-theme

Intelligent needle tracking using ultrasound imaging for improved minimally invasive interventions

Developments in medical care are driven by increasing patient care quality and reducing cost. In the field of anaesthesia, the use of regional techniques has led to improved patient outcome and reduced costs compared to general anaesthesia. However, only 60% of anaesthesiologists perform peripher...

Awarded: NOK 6.1 mill.

Project Period: 2015-2018

Location: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Female cancer prediction using cervical omics to individualise screening and prevention

While prevention of most female specific cancers (ovarian, breast, endometrial) has not progressed substantially in recent years, significant progress has been made with cervical cancer due to accessibility of the cell of origin (cervical smear) and availability of a test for the causal agent (hu...

Awarded: NOK 2.3 mill.

Project Period: 2015-2020

Location: Vestland

H20-SECURITY-Secure societies - Protecting freedom and security of Europe and its citizens

INTEGRATED AND ADAPTIVE RESPONSES TO TOXIC EMERGENCIES FOR RAPID TRIAGE: ENGINEERING THE ROADMAP FROM CASUALTY TO PATIENT TO SURVIVOR.

The seven specific objectives of TOXI-triage address the operational; technological; ethical and societal dimensions of CBRN response and recovery, and importantly the economic base from which sustainable CBRN and multi-use systems are derived. 19 partners in 4 Task forces will deliver 9 Work Pac...

Awarded: NOK 6.2 mill.

Project Period: 2015-2019

Location: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Dynamic hormone diagnostics

We propose to revolutionize current endocrine diagnostics by replacing conventional, time-consuming single-analyte hormone assays with ambulatory dynamic endocrine diagnostics. Disorders of the adrenal and pituitary endocrine systems are not only accompanied by changes in absolute hormone levels,...

Awarded: NOK 16.7 mill.

Project Period: 2015-2020

Location: Vestland

H20-MSCA-Marie Sklodowska-Curie actions

MELanoma GENetics - understanding and biomarking the genetic and immunological determinants of melanoma survival

MELGEN (MELanoma GENetics) – understanding and biomarking the genetic and immunological determinants of melanoma survival The MELGEN European Training Network (ETN) will create an environment for long-term, collaborative, inter-sectorial cancer genetics research with the ultimate aim of improvin...

Awarded: NOK 4.8 mill.

Project Period: 2015-2019

Location: Oslo

H20-HEALTH-Health, demographic change and wellbeing

PREvention of Complications to Improve OUtcome in elderly patients with acute Stroke

Every year, 1.3 million Europeans have a stroke and one million ultimately die of stroke. One third of stroke patients remain dependent on the help of others. The annual costs for stroke care in Europe are estimated at € 64.1 billion. Stroke incidence increases almost exponentially with age, and ...

Awarded: NOK 4.0 mill.

Project Period: 2015-2022

Location: Oslo

H20-HEALTH-Health, demographic change and wellbeing

Aging Lungs in European Cohorts

This programme of work will advance the understanding of the combined effects of factors that cause poor lung function, respiratory disability and the development of COPD . This will be achieved by examination of determinants of lung growth and lung function decline within existing cohorts that c...

Awarded: NOK 4.6 mill.

Project Period: 2015-2019

Location: Vestland

H20-HEALTH-Health, demographic change and wellbeing

Regenerative treatment of complete Traumatic Spinal Cord injury with a surgical implantation of a biodegradable device with FGF1 and nerve grafts

Today there is no regenerative therapy available for treatment of complete spinal cord injuries (SCI). BioArctic Neuroscience develops a novel treatment of complete SCI. The method is based on the regeneration of functional nerves in the injured spinal cord. Nerve grafts are transplanted into the...

Awarded: NOK 8.1 mill.

Project Period: 2015-2019

Location: Vestland

SECURITY-1.10 Security

Online and Mobile Communications for Emergencies

-

Awarded: NOK 1.5 mill.

Project Period: 2014-2017

Location: Hordaland

ICT-1.03 Information and Communication Technologies

Future Internet Social and Technological Alignment Research

-

Awarded: NOK 4.5 mill.

Project Period: 2013-2015

Location: Nordland